Related Experiment Videos
Summary
Testosterone propionate treatment induced prostate adenocarcinoma in Sprague-Dawley rats. Transplanted cells (PA-SD1) metastasized to lungs and caused bone lesions, confirming tumorogenicity.
Area of Science:
- Oncology
- Endocrinology
- Veterinary Pathology
Background:
- Prostate adenocarcinoma is a significant health concern.
- Hormonal influences, like testosterone, are implicated in prostate cancer development.
- Animal models are crucial for studying prostate cancer progression and metastasis.
Purpose of the Study:
- To investigate the induction of prostate adenocarcinoma in Sprague-Dawley rats using testosterone propionate.
- To characterize the metastatic potential and pathological effects of transplanted prostate cancer cells (PA-SD1).
- To confirm the tumorogenicity of in vitro-propagated PA-SD1 cells.
Main Methods:
- Administration of testosterone propionate in silastic membranes to Lobund Sprague-Dawley rats.
- Transplantation of established prostate cancer cells (PA-SD1) into syngeneic rats.
- Monitoring tumor development, metastasis via lymphatic channels, and induced bone lesions.
- In vitro propagation and subsequent in vivo testing of PA-SD1 cells.
Main Results:
- Development of prostate adenocarcinoma in a treated rat.
- PA-SD1 cells formed local tumors and metastasized to the lungs.
- Tumor cell deposition near the calvarium induced osteolytic bone lesions.
- In vitro-cultured PA-SD1 cells retained their ability to produce the original tumor type in vivo.
Conclusions:
- Testosterone propionate can induce prostate adenocarcinoma in Sprague-Dawley rats.
- PA-SD1 cells are capable of local tumor formation, lymphatic metastasis, and inducing bone lesions.
- In vitro propagation maintains the oncogenic potential of PA-SD1 cells, validating their use in further research.